276 related articles for article (PubMed ID: 32045146)
21. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
Koelsche C; Stichel D; Griewank KG; Schrimpf D; Reuss DE; Bewerunge-Hudler M; Vokuhl C; Dinjens WNM; Petersen I; Mittelbronn M; Cuevas-Bourdier A; Buslei R; Pfister SM; Flucke U; Mechtersheimer G; Mentzel T; von Deimling A
Clin Sarcoma Res; 2019; 9():2. PubMed ID: 30809375
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous undifferentiated pleomorphic sarcoma is a pleomorphic dermal sarcoma.
Cohen PR
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621710
[TBL] [Abstract][Full Text] [Related]
24. Relation Between Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Histopathologic Features and Review of the Literature.
Iglesias-Pena N; Martínez-Campayo N; López-Solache L
Actas Dermosifiliogr (Engl Ed); 2021 May; 112(5):392-405. PubMed ID: 33301761
[TBL] [Abstract][Full Text] [Related]
25. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
26. Atypical Fibroxanthoma.
Chapman LW; Yu SS; Arron ST
Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
[TBL] [Abstract][Full Text] [Related]
27. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
[TBL] [Abstract][Full Text] [Related]
28. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
[TBL] [Abstract][Full Text] [Related]
29. Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.
Brenn T
Head Neck Pathol; 2020 Mar; 14(1):109-120. PubMed ID: 31950467
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
[TBL] [Abstract][Full Text] [Related]
31. Aberrant Melan-A expression in atypical fibroxanthoma and undifferentiated pleomorphic sarcoma of the skin.
Thum C; Hollowood K; Birch J; Goodlad JR; Brenn T
J Cutan Pathol; 2011 Dec; 38(12):954-60. PubMed ID: 22050092
[TBL] [Abstract][Full Text] [Related]
32. Pleomorphic Dermal Sarcoma of the Scalp.
Klebanov N; Hoang MP; Reddy BY
Cureus; 2018 Jul; 10(7):e2979. PubMed ID: 30237940
[TBL] [Abstract][Full Text] [Related]
33. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
[TBL] [Abstract][Full Text] [Related]
34. Atypical fibroxanthoma: new insights.
Hussein MR
Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
Logan IT; Vroobel KM; le Grange F; Perrett CM
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
[TBL] [Abstract][Full Text] [Related]
36. Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.
Zeller J; Kiefer J; Braig D; Winninger O; Kraus D; Hagelstein S; Eisenhardt SU
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740535
[TBL] [Abstract][Full Text] [Related]
37. Pleomorphic dermal sarcoma: it might be rare but it exists.
Seretis K; Klaroudas A; Galani V; Papathanakos G; Varouktsi A; Mitselou A; Batistatou A; Lampri E
J Surg Case Rep; 2023 Aug; 2023(8):rjad374. PubMed ID: 37545789
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma: An analysis of 105 tumors.
Bitel A; Schönlebe J; Krönert C; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
[TBL] [Abstract][Full Text] [Related]
39. The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma.
Crisan D; Schneider LA; Scharffetter-Kochanek K; Bernhard L; Crisan M; Wortsman X
J Ultrasound Med; 2024 May; ():. PubMed ID: 38703399
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Signature of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Expression of Hypoxia-inducible Factor-1α and Several of Its Downstream Targets.
Toberer F; Winkler JK; Haenssle HA; Heinzel-Gutenbrunner M; Enk A; Hartschuh W; Helmbold P; Kutzner H; Helbig D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):25-31. PubMed ID: 36153716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
